Our results provide the first evidence that ECFCs, which contribute to the angiogenic switch in BC [19, 21], are insensitive to VEGF due to the attenuation of pro-angiogenic intracellular Ca2+ oscillations that arise upon VEGFR-2 activation in normal cells. This evidence concerns the gene VEGFA and breast cancer.